Results 281 to 290 of about 194,026 (392)

Nissen fundoplicationvsproton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale

, 2017
Chao Zhang, Zhiwei Hu, Chao Yan, Qiong Wu, Ji-Min Wu, Xing Du, Dian-gang Liu, Tao Luo, Fei Li, Zhonggao Wang   +9 more
openalex   +2 more sources

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

Proton pump inhibitor use and pancreatic risk: evidence from the UK biobank participants and animal experiments. [PDF]

Front Pharmacol
Gao X, Xu Z, Liu Q, Yuan C, Dong X, Shi X, Zhu Q, Wu K, Xu H, Pan J, Lu G, Xiao W, Wang S, Wang Y.   +13 more
europepmc   +1 more source

Proton pump inhibitors: perspectives of patients and their GPs.

, 2001
Andrew Williams
openalex   +1 more source

Gastric ulcer healing after treatment of endoscopic submucosal dissection in Japanese: comparison of H2 receptor antagonist and proton pump inhibitor administration

, 2011
Nozomi Takeuchi, Eiji Umegaki, Toshihisa Takeuchi, Mitsuyuki Murano, Yukiko Yoda, Satoshi Tokioka, Kazuhide Higuchi   +6 more
openalex   +2 more sources

Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

Arthritis &Rheumatology, Accepted Article.
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli, Diane Lacaille, Na Lu, Hui Xie, J. Antonio Aviña‐Zubieta   +4 more
wiley   +1 more source

Irrational proton pump inhibitor use during corticosteroid therapy

The Egyptian Journal of Internal Medicine, 2018
Rakesh Agarwal, Rashmi Baid
doaj   +1 more source

Long-Term Proton Pump Inhibitor Therapy and Risk of Gastric Atrophy and Precancerous Mucosal Changes: A Systematic Review. [PDF]

Cureus
Khalid A, Singla B, Singla S, Kumawat S, Abbas A, Ur Rehman S, Chand P, Bai L, Tajammul A.   +8 more
europepmc   +1 more source

Proton pump inhibitor prescribing patterns in the UK: a primary care database study

Pharmacoepidemiology and Drug Safety, 2016
F. Othman, T. Card, C. Crooks
semanticscholar   +1 more source

A New Era for Using Natural Pigments: The Case of the C50 Carotenoid Called Bacterioruberin

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Haloarchaea are extremophilic microorganisms belonging to the Archaea domain that require high salt concentrations to live, thus inhabiting ecosystems like salty ponds, salty marshes, or extremely salty lagoons. They are more abundant and widely distributed worldwide than initially expected.
Micaela Giani, Elena Valdés, José María Miralles‐Robledillo, Guillermo Martínez, Carmen Pire, Rosa María Martínez‐Espinosa   +5 more
wiley   +1 more source